| NEPH Stock | | | USD 1.55 0.04 2.65% |
This module uses fundamental data of Nephros to approximate its Piotroski F score. Nephros F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Nephros. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Nephros financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out
Nephros Altman Z Score,
Nephros Correlation,
Nephros Valuation, as well as analyze
Nephros Alpha and Beta and
Nephros Hype Analysis.
For more detail on how to invest in Nephros Stock please use our
How to Invest in Nephros guide.
As of now, Nephros'
Cash Flow To Debt Ratio is decreasing as compared to previous years. As of now, Nephros'
Operating Cash Flow Per Share is increasing as compared to previous years. The Nephros' current
Average Payables is estimated to increase to about 1.2
M, while
Price To Sales Ratio is projected to decrease to 2.40.
At this time, it appears that Nephros' Piotroski F Score is Poor. Although some professional money managers and academia have recently criticized
Piotroski F-Score model, we still consider it an effective method of
predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
4.0
Piotroski F Score - Poor
| Change in Return on Assets | |
| Cash Flow Return on Assets | |
| Current Quality of Earnings (accrual) | |
| Long Term Debt Over Assets Change | Lower Leverage| Focus | |
| Change In Outstending Shares | |
Nephros Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Nephros is to make sure Nephros is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Nephros' auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Nephros' financial numbers are properly reported.
Nephros F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical
financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Nephros' different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Nephros in a much-optimized way.
Click cells to compare fundamentals
About Nephros Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled
Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Nephros Current Valuation Drivers
We derive many important indicators used in calculating different scores of Nephros from analyzing Nephros' financial statements. These drivers represent accounts that assess Nephros' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Nephros' important valuation drivers and their relationship over time.
About Nephros Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nephros's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nephros using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at
the intrinsic value of Nephros based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing
financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our
fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Nephros
offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nephros'
financial statements, including income statements, balance sheets, and cash flow statements, to assess its
financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nephros Stock.
Outlined below are crucial reports that will aid in making a well-informed decision on Nephros Stock: Is Household Appliances space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost
the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share | Revenue Per Share | Quarterly Revenue Growth | Return On Assets | Return On Equity |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine
if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.